Efficacy of Latanoprostene Bunod 0.024% vs. Timolol Maleate 0.5% for Intraocular Pressure Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension: the LUNAR Study

被引：0

作者：

Peace, James H. ^{[1
]}

Medeiros, Felipe A. ^{[2
]}

Martin, Keith R. ^{[3
,4
]}

Vittitow, Jason L. ^{[5
]}

Weinreb, Robert N. ^{[2
,6
]}

机构：

[1] United Med Res Inst, Inglewood, CA USA

[2] Univ Calif San Diego, Shiley Eye Inst, Hamilton Glaucoma Ctr, La Jolla, CA 92093 USA

[3] Addenbrookes Hosp, Eye Dept, Cambridge, England

[4] Cambridge NIHR Biomed Res Ctr, Cambridge, England

[5] Bausch Lomb, Clin Affairs, Bridgewater, NJ USA

[6] Univ Calif San Diego, Dept Ophthalmol, La Jolla, CA 92093 USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2016年 / 57卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

3035

引用

页数：3

共 50 条

[31] Fixed Combination of Travoprost and Timolol Maleate Reduces Intraocular Pressure in Japanese Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: A Prospective Multicenter Open-Label Study
Nakano, Tadashi
Mizoue, Shiro
Fuse, Nobuo
Iwase, Aiko
Matsumoto, Shun
Yoshikawa, Keiji
ADVANCES IN THERAPY, 2015, 32 (09) : 823 - 837
[32] Effects of Latanoprost 0.005%/ Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
Yuce, Berna
Yilmaz, Suzan Guven
Andac, Kutay
Ates, Halil
TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2012, 42 (01): : 5 - 10
[33] Efficacy and safety of latanoprost versus pilocarpine/timolol maleate fixed combination in patients with primary open-angle glaucoma or ocular hypertension
Kaluzny, Jozef
Sobecki, Roman
Czechowicz-Janicka, Krystyna
Kecik, Dariusz
Kaluzny, Bartlomiej J.
Stewart, Jeanette A.
Stewart, William C.
ACTA OPHTHALMOLOGICA, 2008, 86 (08) : 860 - 865
[34] The long-term safety and efficacy of timolol maleate gel forming solution in patients with open-angle glaucoma or ocular hypertension
Silver, LH
Garadi, R
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S513 - S513
[35] Efficacy and Safety of Latanoprost Versus the Pilocarpine/Timolol Maleate Fixed Combination in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
Kaluzny, J.
Sobecki, R.
Czechowicz-Janicka, K.
Kecik, D.
Stewart, J. A.
Stewart, W. C.
PROCEEDINGS OF THE 7TH INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2008, : 143 - +
[36] Short-term Efficacy and Safety of Latanoprostene Bunod Therapy for Patients with Primary Open-angle Glaucoma
Son, Sun Myung
Kim, Jung Lim
JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY, 2025, 66 (02): : 114 - 119
[37] LATANOPROSTENE BUNOD FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION: SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
Royer, C.
Beauchemin, C.
Lachaine, J.
Cui, A.
Gervais, Jobin K.
Barbeau, M.
VALUE IN HEALTH, 2019, 22 : S363 - S363
[38] The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients With Open-angle Glaucoma or Ocular Hypertension
Manni, Gianluca
Denis, Phillipe
Chew, Paul
Sharpe, Elisabeth D.
Orengo-Nania, Silvia
Coote, Michael A.
Laganovska, Guna
Volksone, Lasma
Zeyen, Thierry
Filatori, Isabella
James, John
Aung, Tin
JOURNAL OF GLAUCOMA, 2009, 18 (04) : 293 - 300
[39] The Safety and Efficacy of Brinzolamide 1%/Timolol 0.5% Fixed Combination Versus Dorzolamide 2%/Timolol 0.5% in Patients with Open-Angle Glaucoma or Ocular Hypertension
Akcay, Betul Ilkay Sezgin
Guney, Esra
Bozkurt, Kansu Tahir
Unlu, Cihan
Akcali, Gulunay
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, 29 (10) : 882 - 886
[40] Brimonidine 0.2% vs unoprostone 0.15% both added to timolol maleate 0.5% given twice daily to patients with primary open-angle glaucoma or ocular hypertension
Sharpe, ED
Henry, CJ
Mundorf, TK
Day, DG
Stewart, JA
Jenkins, JN
Stewart, WC
EYE, 2005, 19 (01) : 35 - 40

← 1 2 3 4 5 →